Correlation Between Mercedes-Benz Group and BB Biotech

Can any of the company-specific risk be diversified away by investing in both Mercedes-Benz Group and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mercedes-Benz Group and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mercedes Benz Group AG and BB Biotech AG, you can compare the effects of market volatilities on Mercedes-Benz Group and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mercedes-Benz Group with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mercedes-Benz Group and BB Biotech.

Diversification Opportunities for Mercedes-Benz Group and BB Biotech

0.4

Correlation Coefficient

Mercedes-Benz Group  BB Biotech

Very weak diversification

The 3 months correlation between Mercedes-Benz and BBZA is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Mercedes Benz Group AG and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Mercedes-Benz Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mercedes Benz Group AG are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Mercedes-Benz Group i.e., Mercedes-Benz Group and BB Biotech go up and down completely randomly.

Pair Corralation between Mercedes-Benz Group and BB Biotech

Assuming the 90 days horizon Mercedes Benz Group AG is expected to generate 0.93 times more return on investment than BB Biotech. However, Mercedes Benz Group AG is 1.07 times less risky than BB Biotech. It trades about 0.13 of its potential returns per unit of risk. BB Biotech AG is currently generating about 0.0 per unit of risk. If you would invest  5,283  in Mercedes Benz Group AG on December 2, 2024 and sell it today you would earn a total of  637.00  from holding Mercedes Benz Group AG or generate 12.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Mercedes Benz Group AG  vs.  BB Biotech AG

Mercedes Benz Group

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mercedes Benz Group AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Mercedes-Benz Group may actually be approaching a critical reversion point that can send shares even higher in April 2025.

BB Biotech AG

Risk-Adjusted Performance

Very Weak

Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BB Biotech is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Mercedes-Benz Group and BB Biotech

The main advantage of trading using opposite Mercedes-Benz Group and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mercedes-Benz Group position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.

The idea behind Mercedes Benz Group AG and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.